Invention Grant
- Patent Title: Use of C-type natriuretic peptide variants to treat skeletal dysplasia
-
Application No.: US18157573Application Date: 2023-01-20
-
Publication No.: US12076372B2Publication Date: 2024-09-03
- Inventor: Sherry Bullens , Stuart Bunting , Tianwei Chou , Augustus O. Okhamafe , Christopher P. Price , Daniel J. Wendt , Clarence Yap
- Applicant: BIOMARIN PHARMACEUTICAL INC.
- Applicant Address: US CA Novato
- Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee Address: US CA Novato
- Agency: MARSHALL, GERSTEIN & BORUN LLP
- The original application number of the division: US15225355 2016.08.01
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K9/00 ; A61K9/19 ; A61K38/00 ; A61K38/16 ; A61K38/17 ; A61K47/10 ; A61K47/12 ; A61K47/18 ; A61K47/20 ; A61K47/26
Abstract:
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
Public/Granted literature
- US20230293637A1 Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia Public/Granted day:2023-09-21
Information query
IPC分类:
